Home > Boards > US Listed > Medical - Healthcare > Genprex Inc (GNPX)

News: $GNPX How Africa Plans to Create Its

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
whytestocks Member Profile
 
Followed By 118
Posts 14,981
Boards Moderated 3
Alias Born 06/04/18
160x600 placeholder
Genprex in-licenses additional gene therapy technologies for treatment of lung cancer Seeking Alpha - 5/6/2021 9:31:54 AM
Genprex In-Licenses Additional Gene Therapy Technologies for Treatment of Lung Cancer Business Wire - 5/6/2021 9:05:00 AM
Genprex receives IRB approval for NSCLC gene therapy trial; shares up 4% Seeking Alpha - 5/5/2021 9:21:10 AM
Genprex Announces Centralized Institutional Review Board Approval for Acclaim-1 Clinical Trial in Non-Small Cell Lung Cancer Business Wire - 5/5/2021 8:55:00 AM
Genprex Initiates Site Recruitment for Acclaim-2 Clinical Trial for the Treatment of Non-Small Cell Lung Cancer Business Wire - 5/4/2021 9:32:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/30/2021 4:14:32 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/30/2021 4:14:20 PM
Genprex to Participate in CEO Roadshow Webinar Series Business Wire - 4/21/2021 8:30:00 AM
Genprex to Receive Inaugural “License of the Year” Award from University of Pittsburgh Innovation Institute in Recognitio... Business Wire - 4/20/2021 8:30:00 AM
Genprex's Reqorsa combo shows encouraging activity in lung cancer, shares up 3% Seeking Alpha - 4/12/2021 8:54:18 AM
Genprex Collaborators Report Positive Preclinical Data for REQORSA™ Immunogene Therapy in Non-Small Cell Lung Cancer at the... Business Wire - 4/12/2021 8:30:00 AM
Auris Medical, Prometheus Biosciences leads healthcare gainers; Endo International, Odonate Therapeutics among major losers Seeking Alpha - 4/8/2021 11:05:06 AM
Amended Statement of Beneficial Ownership (3/a) Edgar (US Regulatory) - 4/7/2021 4:38:36 PM
Genprex to Present at the 2021 Virtual Cell & Gene Meeting on the Mediterranean Business Wire - 4/5/2021 8:30:00 AM
Genprex Announces Preclinical Data for TUSC2 Immunogene Therapy in Non-Small Cell Lung Cancer to Be Featured in Two Presentat... Business Wire - 3/30/2021 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/25/2021 7:06:19 PM
Genprex to Present at the Spring 2021 Oncology Investor Conference on March 29 Business Wire - 3/24/2021 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/23/2021 4:49:45 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/23/2021 4:49:12 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/23/2021 4:47:27 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/9/2021 9:07:13 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/2/2021 4:45:40 PM
Genprex to Participate in Upcoming March Investor Conferences Business Wire - 3/1/2021 8:30:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/19/2021 1:09:56 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/16/2021 9:47:19 AM
whytestocks   Friday, 08/14/20 03:00:42 PM
Re: None
Post # of 3752 
News: $GNPX How Africa Plans to Create Its Own Medical Technology

Some technological advancements, such as biomedical engineering, can be used in saving lives because the biomedical engineering field draws knowledge from different disciplines such as computer science, public health, clinical practice and biomedical sciences. The information from these four...

Find out more GNPX - How Africa Plans to Create Its Own Medical Technology

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences